custom search
8/2/2012
REVERSED
3700 Mechanical Engineering, Manufacturing, and Products & Design
3737 Ex Parte Leitner et al 10348583 - (D) McCOLLUM 103 RATNERPRESTIA MEHTA, PARIKHA SOLANKI
AFFIRMED
3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3658 Ex Parte LeBlanc et al 11166823 - (D) HORNER 103 Tabarrok & Zahrt (SEAGATE-10/11) KRAUSE, JUSTIN MITCHELL
3700 Mechanical Engineering, Manufacturing, and Products & Design
3731 Ex Parte Van Heugten et al 11288745 - (D) GRIMES 103 DICKINSON WRIGHT PLLC SIMPSON, SARAH A
3736 Ex Parte Geiger 10976164 - (D) WALSH 103 SHUMAKER & SIEFFERT, P. A. NGUYEN, HUONG Q
3736 Ex Parte Bodecker et al 10579265 - (D) DEMETRA J. MILLS 103 JOHNSON & JOHNSON STOUT, MICHAEL C
8/3/2012
REVERSED
3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3643 Ex Parte La Croix 12470176 - (D) GRIMES 103 QUARLES & BRADY LLP NGUYEN, SON T
3700 Mechanical Engineering, Manufacturing, and Products & Design
3731 Ex Parte Bettuchi et al 11238497 - (D) FREDMAN 103 Tyco Healthcare Group LP d/b/a Covidien SEVERSON, RYAN J
AFFIRMED-IN-PART
1600 Biotechnology and Organic Chemistry
1631 Ex Parte Bangera et al 11729958 - (D) GREEN 112(1)/obviousness-type double patenting obviousness-type double patenting THE INVENTION SCIENCE FUND CLARENCE T. TEGREENE BRUSCA, JOHN S
“‘[T]he enablement requirement is met if the description enables any mode of making and using the invention.’” Johns Hopkins Univ. v. CellPro, Inc., 152 F.3d 1342, 1361 (Fed. Cir. 1998) (quoting Engel Indus., Inc. v. Lockformer Co., 946 F.2d 1528, 1533 (Fed. Cir. 1991)).
AFFIRMED
2100 Computer Architecture and Software
2172 Ex Parte Dobbelaar 10123790 - (D) DESHPANDE 102/103 PHILIPS INTELLECTUAL PROPERTY & STANDARDS ENGLAND, SARA M
3700 Mechanical Engineering, Manufacturing, and Products & Design
3733 Ex Parte Cuellar et al 11251044 - (D) FREDMAN 103 MCCRACKEN & FRANK LLC MERENE, JAN CHRISTOP L
3900 Central Reexamination Unit (CRU)
3900 Ex parte ISIS Pharmaceuticals, Inc. Appellant 90010867 5670633 07/835,932 LEBOVITZ 103 WOODCOCK WASHBURN LLP PONNALURI, PADMASHRI
